NCT05506982View on ClinicalTrials.gov

Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

April 25, 2024

Study Completion Date

January 24, 2025

Conditions
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Interventions
DRUG

Psilocybin

Given PO

BEHAVIORAL

Psychotherapy

supportive care

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (2)

30322

Emory University/Winship Cancer Institute, Atlanta

30329

Brain Health Center at Executive Park, Atlanta

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Emory University

OTHER